mcc-555 has been researched along with rosiglitazone in 6 studies
Studies (mcc-555) | Trials (mcc-555) | Recent Studies (post-2010) (mcc-555) | Studies (rosiglitazone) | Trials (rosiglitazone) | Recent Studies (post-2010) (rosiglitazone) |
---|---|---|---|---|---|
26 | 0 | 5 | 4,749 | 556 | 1,818 |
Protein | Taxonomy | mcc-555 (IC50) | rosiglitazone (IC50) |
---|---|---|---|
CDGSH iron-sulfur domain-containing protein 1 | Rattus norvegicus (Norway rat) | 1.1 | |
Bile salt export pump | Homo sapiens (human) | 4.5853 | |
Carbonic anhydrase 2 | Homo sapiens (human) | 4.069 | |
Peroxisome proliferator-activated receptor alpha | Mus musculus (house mouse) | 0.08 | |
Thromboxane-A synthase | Homo sapiens (human) | 3.56 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.832 | |
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.2481 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.038 | |
ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.048 | |
ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.048 | |
Sodium/bile acid cotransporter | Homo sapiens (human) | 5.1 | |
CDGSH iron-sulfur domain-containing protein 2 | Homo sapiens (human) | 2.29 | |
CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | 0.731 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kadowaki, T | 1 |
Brüne, B; Loitsch, S; Stein, J; Ulrich, S; von Knethen, A; Wächtershäuser, A | 1 |
Lazarenko, OP; Lecka-Czernik, B; Rzonca, SO; Suva, LJ | 1 |
Blay, J; Richard, CL | 1 |
Giaginis, C; Theocharis, S; Tsantili-Kakoulidou, A | 1 |
Flier, JS; Gardner, NP; Guan, HP; Kershaw, EE; Lazar, MA; Schupp, M | 1 |
1 review(s) available for mcc-555 and rosiglitazone
Article | Year |
---|---|
[Insulin-sensitizing agents].
Topics: Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Isoxazoles; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones | 1999 |
5 other study(ies) available for mcc-555 and rosiglitazone
Article | Year |
---|---|
Activation of PPARgamma is not involved in butyrate-induced epithelial cell differentiation.
Topics: Alkaline Phosphatase; Apoptosis; Butyrates; Caco-2 Cells; Cell Cycle Proteins; Cell Differentiation; Cell Proliferation; Colonic Neoplasms; Epithelial Cells; Humans; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones | 2005 |
Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat.
Topics: Adipocytes; Animals; Bone Density; Bone Marrow Cells; Cell Culture Techniques; Cell Differentiation; Cell Line; Culture Media; Dose-Response Relationship, Drug; Gene Expression Regulation; Genetic Markers; Ligands; Male; Mice; Mice, Inbred C57BL; Osteoblasts; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazoles; Thiazolidinediones; Tomography, X-Ray Computed | 2006 |
Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Colorectal Neoplasms; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Pioglitazone; PPAR gamma; Receptors, CXCR4; Rosiglitazone; Thiazolidinediones | 2007 |
Investigation of the lipophilic behaviour of some thiazolidinediones. Relationships with PPAR-gamma activity.
Topics: Chromans; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Lipids; Membranes, Artificial; Octanols; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones; Transcriptional Activation; Troglitazone; Water | 2007 |
PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue, Brown; Adipose Tissue, White; Anilides; Animals; Carboxylic Ester Hydrolases; Cycloheximide; Dietary Fats; Dose-Response Relationship, Drug; Fluorenes; Gene Expression; Leptin; Lipase; Membrane Proteins; Mice; Mice, Inbred Strains; Mice, Knockout; PPAR gamma; Prostaglandin D2; Protein Biosynthesis; RNA, Messenger; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones | 2007 |